Effects of alendronate and alfacalcidol on bone in patients with myasthenia gravis initiating glucocorticoids treatment

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2265|88|3|380-387

ISSN： 0300-0664

Source： CLINICAL ENDOCRINOLOGY, Vol.88, Iss.3, 2018-03, pp. : 380-387

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) –– 02

By Orimo Hajime   Nakamura Toshitaka   Fukunaga Masao   Ohta Hiroaki   Hosoi Takayuki   Uemura Yukari   Kuroda Tatsuhiko   Miyakawa Nobuaki   Ohashi Yasuo   Shiraki Masataka    

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1273-1284

Informa Healthcare

Access to resources Recommend Favorite

Home sleep study for patients with myasthenia gravis

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 132, Iss. 3, 2015-09 ,pp. : 191-195

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of diabetes mellitus among patients with myasthenia gravis

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 132, Iss. 2, 2015-08 ,pp. : 132-138

John Wiley & Sons Inc

Access to resources Recommend Favorite

Autoimmune antibodies to collagen XIII in myasthenia gravis patients

By  

MUSCLE AND NERVE, Vol. 57, Iss. 3, 2018-03 ,pp. : 506-510

John Wiley & Sons Inc

Access to resources Recommend Favorite

Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome

By Feber J.  

Osteoporosis International, Vol. 23, Iss. 2, 2012-02 ,pp. : 751-760

Springer Publishing Company

Access to resources Recommend Favorite